6.66
price down icon3.20%   -0.22
after-market アフターアワーズ: 6.75 0.09 +1.35%
loading
前日終値:
$6.88
開ける:
$6.77
24時間の取引高:
39,963
Relative Volume:
0.25
時価総額:
$57.75M
収益:
$137.27M
当期純損益:
$-123.57M
株価収益率:
-0.6082
EPS:
-10.95
ネットキャッシュフロー:
$-102.89M
1週間 パフォーマンス:
+16.23%
1か月 パフォーマンス:
+5.55%
6か月 パフォーマンス:
+18.93%
1年 パフォーマンス:
-36.30%
1日の値動き範囲:
Value
$6.66
$7.18
1週間の範囲:
Value
$5.32
$7.90
52週間の値動き範囲:
Value
$3.51
$16.95

Karyopharm Therapeutics Inc Stock (KPTI) Company Profile

Name
名前
Karyopharm Therapeutics Inc
Name
セクター
Healthcare (1143)
Name
電話
617-658-0600
Name
住所
85 WELLS AVENUE, NEWTON, MA
Name
職員
279
Name
Twitter
@Karyopharm
Name
次回の収益日
2024-11-05
Name
最新のSEC提出書
Name
KPTI's Discussions on Twitter

KPTI を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
KPTI
Karyopharm Therapeutics Inc
6.66 59.66M 137.27M -123.57M -102.89M -10.95
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
381.87 96.56B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
449.58 60.08B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
555.51 61.15B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
711.09 44.66B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
328.71 36.23B 3.81B -644.79M -669.77M -6.24

Karyopharm Therapeutics Inc Stock (KPTI) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-07-16 ダウングレード H.C. Wainwright Buy → Neutral
2025-07-11 再開されました H.C. Wainwright Buy
2023-01-19 開始されました Piper Sandler Overweight
2022-11-04 アップグレード RBC Capital Mkts Sector Perform → Outperform
2022-02-09 アップグレード JP Morgan Underweight → Neutral
2021-11-19 再開されました Morgan Stanley Equal-Weight
2021-08-06 ダウングレード JP Morgan Overweight → Neutral
2021-08-06 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2021-08-06 ダウングレード SVB Leerink Outperform → Mkt Perform
2020-07-02 開始されました Morgan Stanley Overweight
2020-03-04 開始されました Barclays Overweight
2020-01-17 ダウングレード Wedbush Outperform → Neutral
2019-07-23 アップグレード JP Morgan Neutral → Overweight
2019-07-05 繰り返されました H.C. Wainwright Buy
2019-07-05 繰り返されました Robert W. Baird Outperform
2019-03-01 ダウングレード JP Morgan Overweight → Neutral
2019-02-28 繰り返されました BofA/Merrill Underperform
2019-02-27 ダウングレード BofA/Merrill Neutral → Underperform
2019-01-03 アップグレード BofA/Merrill Underperform → Neutral
2018-12-03 開始されました B. Riley FBR Buy
2018-11-09 アップグレード Wedbush Neutral → Outperform
2018-05-24 ダウングレード Wedbush Outperform → Neutral
2018-04-02 再開されました Leerink Partners Outperform
2017-11-15 再開されました H.C. Wainwright Buy
2017-09-15 開始されました RBC Capital Mkts Outperform
2016-09-08 繰り返されました H.C. Wainwright Buy
2016-08-30 アップグレード Jefferies Hold → Buy
2016-08-18 開始されました H.C. Wainwright Buy
2016-06-28 開始されました Robert W. Baird Outperform
すべてを表示

Karyopharm Therapeutics Inc (KPTI) 最新ニュース

pulisher
Sep 24, 2025

Karyopharm Therapeutics (KPTI) Moves 27.9% Higher: Will This Strength Last? - Nasdaq

Sep 24, 2025
pulisher
Sep 23, 2025

Smart tools for monitoring Karyopharm Therapeutics Inc.’s price actionWeekly Stock Recap & Weekly High Momentum Picks - newser.com

Sep 23, 2025
pulisher
Sep 23, 2025

Karyopharm increases authorized shares, approves reverse split - MSN

Sep 23, 2025
pulisher
Sep 22, 2025

Ideas Watch: Can Karyopharm Therapeutics Inc disrupt its industryMarket Sentiment Review & Weekly Top Gainers Alerts - خودرو بانک

Sep 22, 2025
pulisher
Sep 21, 2025

Karyopharm Therapeutics Inc.(NasdaqGS: KPTI) dropped from S&P Global BMI Index - MarketScreener

Sep 21, 2025
pulisher
Sep 20, 2025

Market Overview: Is Karyopharm Therapeutics Incs ROIC above industry average2025 Stock Rankings & Capital Efficiency Focused Ideas - خودرو بانک

Sep 20, 2025
pulisher
Sep 19, 2025

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Receives $34.00 Consensus Price Target from Analysts - MarketBeat

Sep 19, 2025
pulisher
Sep 19, 2025

Death Cross: Is Karyopharm Therapeutics Incs growth already priced inCEO Change & Fast Exit Strategy with Risk Control - khodrobank.com

Sep 19, 2025
pulisher
Sep 17, 2025

Is Karyopharm Therapeutics Inc. stock entering bullish territoryJuly 2025 Drop Watch & Free Expert Verified Stock Movement Alerts - newser.com

Sep 17, 2025
pulisher
Sep 17, 2025

Risk Check: Can Bread Financial Holdings Inc continue delivering strong returnsLayoff News & Free Accurate Trade Setup Notifications - خودرو بانک

Sep 17, 2025
pulisher
Sep 17, 2025

Aug Rallies: Is Cartesian Growth Corporation Equity Warrant forming a double bottomEarnings Trend Report & Safe Entry Trade Signal Reports - khodrobank.com

Sep 17, 2025
pulisher
Sep 17, 2025

Insider Buy: Will Karyopharm Therapeutics Inc. benefit from rate cuts2025 Key Highlights & Entry Point Confirmation Signals - خودرو بانک

Sep 17, 2025
pulisher
Sep 16, 2025

Karyopharm CEO Paulson sells $8k in shares By Investing.com - Investing.com South Africa

Sep 16, 2025
pulisher
Sep 16, 2025

Karyopharm therapeutics EVP Cheng sells $2089 in stock By Investing.com - Investing.com Canada

Sep 16, 2025
pulisher
Sep 16, 2025

Karyopharm Therapeutics Board Member Resigns Amid Career Shift - MSN

Sep 16, 2025
pulisher
Sep 16, 2025

Karyopharm therapeutics EVP Cheng sells $2089 in stock - Investing.com India

Sep 16, 2025
pulisher
Sep 16, 2025

Karyopharm CEO Paulson sells $8k in shares - Investing.com India

Sep 16, 2025
pulisher
Sep 16, 2025

Aug Wrap: Is SLM Corporation part of any major indexWeekly Market Report & Low Risk Profit Maximizing Plans - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Gap Down: Is Karyopharm Therapeutics Inc gaining market share2025 Investor Takeaways & Technical Pattern Based Signals - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Volatility Watch: What are Karyopharm Therapeutics Inc.’s recent SEC filings showingQuarterly Profit Report & AI Based Trade Execution Alerts - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Entry Recap: Will Karyopharm Therapeutics Inc. benefit from current market trends2025 Top Gainers & Stock Portfolio Risk Control - خودرو بانک

Sep 16, 2025
pulisher
Sep 15, 2025

Wall Street Recap: Is Karyopharm Therapeutics Inc gaining market shareJuly 2025 Action & Fast Gain Stock Tips - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Volume Report: What are Karyopharm Therapeutics Inc.’s recent SEC filings showingWeekly Trade Report & Reliable Trade Execution Plans - khodrobank.com

Sep 15, 2025
pulisher
Sep 15, 2025

These biotechs are in the market for a buyer - The Business Journals

Sep 15, 2025
pulisher
Sep 15, 2025

Income Plays: Will Karyopharm Therapeutics Inc outperform its industry peersTrade Analysis Summary & Short-Term Swing Trade Alerts - خودرو بانک

Sep 15, 2025
pulisher
Sep 13, 2025

Karyopharm Therapeutics Inc. $KPTI Position Reduced by Adage Capital Partners GP L.L.C. - MarketBeat

Sep 13, 2025
pulisher
Sep 11, 2025

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Held Back By Insufficient Growth Even After Shares Climb 65% - simplywall.st

Sep 11, 2025
pulisher
Sep 11, 2025

Karyopharm concludes enrolment in Phase III myelofibrosis treatment trial - Yahoo Finance

Sep 11, 2025
pulisher
Sep 11, 2025

Karyopharm completes enrollment in phase 3 myelofibrosis trial By Investing.com - Investing.com Australia

Sep 11, 2025
pulisher
Sep 10, 2025

Karyopharm completes enrollment in phase 3 myelofibrosis trial - Investing.com India

Sep 10, 2025
pulisher
Sep 10, 2025

Karyopharm Announces Completion of Enrollment in the Phase 3 SENTRY Trial in Myelofibrosis - Citizen Tribune

Sep 10, 2025
pulisher
Sep 10, 2025

Karyopharm announces completion of enrollment in the phase 3 SENTRY trial in myelofibrosis - MarketScreener

Sep 10, 2025
pulisher
Sep 08, 2025

Published on: 2025-09-08 20:44:00 - beatles.ru

Sep 08, 2025
pulisher
Sep 08, 2025

Karyopharm Therapeutics Inc. Recovery Gathers Momentum on Chart SignalsWatch List & Technical Analysis for Trade Confirmation - beatles.ru

Sep 08, 2025
pulisher
Sep 08, 2025

Palo Alto Investors LP Cuts Stock Holdings in Karyopharm Therapeutics Inc. $KPTI - MarketBeat

Sep 08, 2025
pulisher
Sep 08, 2025

Birchview Capital LP Trims Holdings in Karyopharm Therapeutics Inc. $KPTI - MarketBeat

Sep 08, 2025
pulisher
Sep 07, 2025

Is Karyopharm Therapeutics Inc. gaining market share2025 Earnings Surprises & Technical Analysis for Trade Confirmation - classian.co.kr

Sep 07, 2025
pulisher
Sep 06, 2025

Analyzing recovery setups for Karyopharm Therapeutics Inc. investorsJuly 2025 Rallies & Verified Momentum Stock Ideas - Newser

Sep 06, 2025
pulisher
Sep 06, 2025

Multi factor analysis applied to Karyopharm Therapeutics Inc.2025 Support & Resistance & Daily Profit Maximizing Trade Tips - Newser

Sep 06, 2025
pulisher
Sep 06, 2025

Will Karyopharm Therapeutics Inc. benefit from current market trendsMarket Weekly Review & Daily Stock Trend Reports - خودرو بانک

Sep 06, 2025
pulisher
Sep 06, 2025

Can Karyopharm Therapeutics Inc. recover in the next quarterJuly 2025 Final Week & Daily Profit Focused Stock Screening - Newser

Sep 06, 2025
pulisher
Sep 06, 2025

Is Karyopharm Therapeutics Inc. benefiting from innovation trendsJuly 2025 Trends & Free Community Supported Trade Ideas - خودرو بانک

Sep 06, 2025
pulisher
Sep 05, 2025

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - 富途牛牛

Sep 05, 2025
pulisher
Sep 05, 2025

Karyopharm Therapeutics Inc. stock daily chart insights2025 Retail Activity & Low Drawdown Trading Techniques - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Is Karyopharm Therapeutics Inc. trending in predictive chart modelsMarket Risk Report & Fast Moving Stock Watchlists - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

What candlestick patterns are forming on Karyopharm Therapeutics Inc.Weekly Trend Recap & High Conviction Buy Zone Alerts - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Using data tools to time your Karyopharm Therapeutics Inc. exitJuly 2025 Setups & Weekly Watchlist for Hot Stocks - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Layoff Tracker: AC Immune To Cut 30% of Workforce - BioSpace

Sep 05, 2025

Karyopharm Therapeutics Inc (KPTI) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$34.90
price down icon 2.43%
$81.66
price down icon 2.97%
$28.84
price down icon 2.07%
$98.08
price down icon 1.67%
$135.59
price down icon 3.84%
biotechnology ONC
$328.71
price down icon 0.34%
大文字化:     |  ボリューム (24 時間):